We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Smoking May Trigger Pancreatic Cancer

By Biotechdaily staff writers
Posted on 22 Nov 2004
Tobacco may serve as an environmental trigger for patients with an inherited genetic predispostion to pancreatic cancer, according to a new study in the December 15, 2004, issue of Cancer.

Pancreatic cancer is rare and poorly studied. It is known that it is an aggressive cancer, with a five-year survival of only 4%. A small percentage of patients with pancreatic cancer have first-degree relatives with pancreatic cancer. Smoking has been identified as the single most-important risk factor in familial pancreatic adenocarcinoma (FPAC), but the genetic component of the disease has remained a mystery.

The study consisted of a retrospective review of 826 patients with pancreatic cancer. Researchers found that 30 of these had the familial form. This group tended to be younger and to have a history of smoking. Specifically, about 87% of FPAC patients smoked, while only 66% of those with sporadic pancreatic cancer smoked.

"Patients with a family history of pancreatic cancer must be strongly counseled against smoking, and smokers with a family history of pancreatic cancer should be informed of their increased risk and offered enrollment into a smoking cessation program,” concluded the authors of the study, led by Ted A. James, M.D., of the Roswell Park Cancer Institute in Buffalo (NY, USA

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Manual Pipetting Aid
Pipette Controllers macro
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA

Latest BioResearch News

D-Serine May Predict Immune Checkpoint Therapy Resistance in Gastric Cancer
22 Nov 2004  |   BioResearch

New Genetic Cause Identified for Neurodevelopmental Disorder
22 Nov 2004  |   BioResearch

New Genetic Discovery Could Support Precision Diabetes Care
22 Nov 2004  |   BioResearch